INCI · — · CIR review pending · used in 5 products
콩폴리펩타이드
Glycine Max (Soybean) Polypeptide
Evidence level
moderateEWG score
—Comedogenic
—Category
—● Benefits
Benefits to be documented.
● Cautions
No known cautions documented in the catalog.
Benefits to be documented.
No known cautions documented in the catalog.